Almokalant

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C18H28N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) I9NG89L275, chemically known as benzonitrile, 4-(3-(ethyl(3-(propylsulfinyl)propyl)amino)-2-hydroxypropoxy)- but more generally known as almokalant, which bears US NIH Compound Identifier 3033962. European Medicines Agency schedules Almokalant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05349MIG. The term ALMOKALANT is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 5, No. 3 1991, List 31). ALMOKALANT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule almokalant under HS 29309085 and SITC 51549. As of Q4 2014, ALMOKALANT remains US FDA's Preferred Term for this commodity. Almokalant bears US NLM identifiers UMLS ID C0167716 and NCI Concept Code C77828. SMILES: S(=O)(CCCN(CC(O)COC1CCC(CC1)C#N)CC)CCC.